News

Bittium Corporation, Stock Exchange Release, July 11, 2025, at 1.00 pm (CEST+1) Bittium Corporation publishes this stock exchange release to comment on the market information regarding the possible ...
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules ...
Solar Foods partners with Sensapure Flavors to showcase Solein's suitability for endless flavour combinations ...
Prior to joining Bitwise, Shannon served as a Crypto & Equity Research Analyst at CoinShares, where he specialized in liquid tokens and publicly listed crypto-related companies. His expertise in ...
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received order for an NBS 6 system from a distributor. The end customer is a Nordic therapy clinic that is acquiring their first Nexstim system.
Since its launch in the US , Teamspace has seen success with over 7,000 teams created as of Q1 2025. This global expansion enables Xometry to drive deeper enterprise engagement and enhance viral ...
Gold production from ongoing operations of 61,736 ounces; compared to 56,000 oz Au in Q2 20241,2 and 58,820 oz Au in Q1 20251,3 Gold equivalent production from ongoing operations of 71,229 ounces4 ...
Ranked #3 globally in DJ Mag’s Top 100 Festivals, UNTOLD has become a cultural landmark. It hosts live acts like Imagine Dragons, Lenny Kravitz, Bebe Rexha, Major Lazer, Charlie XCX, and Jason Derulo.
In Q2 we were also joined by Gregor Bates, Associate, London, and Analysts Matt Farrell, Nikita Spivakov, and Tim O’Callaghan in New York. We also welcome George Parker, New York, as Senior Advisor ...
SYDNEY, July 09, 2025 (GLOBE NEWSWIRE) -- Siltrax , a pioneering company in fuel-cell innovation, today announced it has achieved the highest recorded volumetric and gravimetric power densities for ...
A new European leadership structure and the integration of Smart Mobile Labs under the Boldyn banner reinforce Boldyn’s position as the leading neutral host and mobile private networks provider in the ...
Earlier this year, Purespring announced that the European Medicines Agency (EMA) had granted orphan drug designation to PS-002 for the treatment of patients with IgAN. This designation followed the ...